Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may cause hair loss due to infection stress or treatments.

Smoking harms skin health, causing slower wound healing, more wrinkles, and worsening some skin conditions, but may protect against certain others.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Hair mesotherapy might help with certain types of hair loss but lacks strong scientific proof and has some risks.

Cronkhite-Canada syndrome can cause multiple gastrointestinal polyps and various physical symptoms.

A high school wrestler's skin rash was cured with antifungal medication after a misdiagnosis and incorrect treatment led to a fungal infection.

Heptaminol may cause hair lightening in hemodialysis patients.

Injecting triamcinolone into the eyebrow area may help eyelash regrowth in alopecia areata patients.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

People with diabetes have a higher risk of skin infections and complications.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

People with advanced chronic kidney disease often have skin problems, which can be treated with various medications and procedures to improve their quality of life.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

Early detection and treatment of primary biliary cirrhosis and related autoimmune diseases improve outcomes.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

Some African American women experience central scalp hair loss, often linked to a history of fungal scalp infection.

Pregnancy can cause skin changes and may affect pre-existing skin conditions, with some treatments not safe for use during pregnancy.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.